Top

Osteoporosis International

Published in:

01-01-2016 | Original Article

Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults

Authors: J. M. Olmos, J. L. Hernández, P. García-Velasco, J. Martínez, J. Llorca, J. González-Macías

Published in: Osteoporosis International | Issue 1/2016

Abstract

Summary

Vitamin D insufficiency is very common among Spanish community-dwelling adult subjects. A threshold of serum 25(OH)D around 30 ng/ml would be necessary for the prevention of secondary hyperparathyroidism and hip bone loss in our population, regardless of the dairy calcium ingestion.

Introduction

This study aims to assess 25-hydroxyvitamin D—25(OH)D—status in Spanish adult subjects and to analyze its relationships with serum PTH levels, calcium intake, and bone mineral density (BMD).

Methods

A total of 1811 individuals (1154 postmenopausal women and 657 men) aged 44–93 years participated in the study. Serum 25(OH)D, intact parathyroid hormone (PTH), aminoterminal propeptide of type I collagen (P1NP), and C-terminal telopeptide of type I collagen (β-CTX) levels were measured by electrochemiluminescence. BMD was determined by dual x-ray absorptiometry (DXA) at lumbar spine, femoral neck, and total hip.

Results

Serum 25(OH)D levels were below 10, 20, and 30 ng/ml in 5, 40, and 83 % of participants, respectively. There was a significant seasonal difference in mean serum 25(OH)D, with higher levels in summer–autumn. In multivariate analysis, 25(OH)D levels were negatively correlated with age, serum PTH and creatinine, body mass index, smoking, alcohol intake, and a number of chronic diseases, but positively with dairy calcium intake. The magnitude of the difference in serum PTH according to 25(OH)D quartiles was not influenced by calcium intake. A threshold of serum 25(OH)D around 30 ng/ml was observed for serum PTH and hip BMD.

Conclusions

Holick MF (2007) Vitamin D, deficiency. N Engl J Med 357:266–281PubMedCrossRef

McKenna MJ (1992) Differences in vitamin D status between countries in young adults and the elderly. Am J Med 93:69–77PubMedCrossRef

Van der Wielen RP, Lowik MR, van der Berg H, de Groot LC, Haller J, Moreiras O, van Staveren WA (1995) Serum vitamin D concentrations among elderly people in Europe. Lancet 346:207–210PubMedCrossRef

Kuchuk NO, van Schoor NM, Pluijm SM, Chines A, Lips P (2009) Vitamin D status, parathyroid function, bone turnover, and BMD in postmenopausal women with osteoporosis: global perspective. J Bone Miner Res 24:693–701PubMedCrossRef

Bruyère O, Slomian J, Beaudart C, Buckinx F, Cavalier E, Gillain S, Petermans J, Reginster JY (2014) Prevalence of vitamin D inadequacy in European women aged over 80 years. Arch Gerontol Geriatr 59:78–82PubMedCrossRef

Spiro A, Buttriss JL, Vitamin D (2014) An overview of vitamin D status and intake in Europe. Nutr Bull 39:322–350PubMedPubMedCentralCrossRef

Lips P (2001) Vitamin D, deficiency and secondary hyperparathyroidism in the elderly: consequences for bone loss and fractures and therapeutic implications. Endocr Rev 22:447–501

Bates CJ, Carter GD, Mishra GD, O’Shea D, Jones J, Prentice A (2003) In a population study, can parathyroid hormone aid the definition of adequate vitamin D status? Osteoporos Int 14:152–159PubMed

Carter GD (2012) 25-Hydroxyvitamin D: a difficult analyte. Clin Chem 58:486–488PubMedCrossRef

10.

Heaney RP (2005) Vitamin D, requirement in health and disease. Steroid Biochem Mol Biol 97:13–19CrossRef

11.

Steingrimsdottir L, Gunnarson O, Indidason OS, Franzson L, Sigurdson G (2005) Relationship between serum parathyroid hormone levels, vitamin D sufficiency, and calcium intake. JAMA 294:2336–2341PubMedCrossRef

12.

Adami S, Viapiana O, Gatti D, Idolazzi L, Rossini M (2008) Relationship between serum parathyroid hormone, vitamin D sufficiency, age, and calcium intake. Bone 42:267–270PubMedCrossRef

13.

Kuchuck NO, Pluijm SM, van Schoor NM, Looman CWN, Smit JH, Lips P (2009) Relationships of serum 25-hydroxyvitamin D to bone mineral density and serum parathyroid hormone and markers of bone turnover in older persons. J Clin Endocrinol Metab 94:1244–1250CrossRef

14.

Hernández JL, Olmos JM, Pariente E, Martínez J, Valero C, García-Velasco P, Nan D, Llorca J, González-Macías J (2010) Metabolic syndrome and bone metabolism. Menopause 17:955–961PubMedCrossRef

15.

Olmos JM, Hernández JL, Martínez J, Pariente E, Llorca J, González-Macías J (2010) Bone turnover markers in Spanish adult men. The Camargo Cohort Study. Clin Chim Acta 411:1511–1515PubMedCrossRef

16.

Díez A, González-Macías J, Marín F, Abizanda M, Alvarez R, Gimeno A, for the ECOSAP study investigators et al (2007) Prediction of absolute risk of non-spinal fractures using clinical risk factors and heel quantitative ultrasound. Osteoporos Int 18:629–639CrossRef

17.

Berry EM, Gupta MM, Turner SJ, Burns RR (1973) Variations in plasma calcium with induced changes in plasma specific gravity, total protein, and albumin. Br Med J 4:640–643PubMedPubMedCentralCrossRef

18.

Looker AC, Orwoll ES, Johnston CC et al (1997) Prevalence of low femoral bone density in older U.S. adults from NHANES III. J Bone Miner Res 12:1761–1768PubMedCrossRef

19.

Riancho JA, Valero C, Hernández JL, Olmos JM, Paule B, Zarrabeitia A, González-Macías J (2007) Biomechanical indices of the femoral neck estimated from the standard DXA output: age- and sex-related differences. J Clin Densitomet 10:39–45CrossRef

20.

Ruston D, Hoare J, Henderson L, Bates CJ, Prentice A, Birch M (2004) National Diet and Nutrition Survey: adults aged 19–64 years. In Volume 4: nutritional status (anthropometry and blood analytes), blood pressure and physical activity. TSO. London

21.

Rockell JEP, Skeaff CM, Williams SM, Green TJ (2006) Serum 25-hydroxyvitamin D concentrations of New Zealanders aged 15 years and older. Osteoporos Int 17:1382–1389PubMedCrossRef

22.

Looker AC, Dawson-Hughes B, Calvo MS, Gunter EW, Sahynoun NR (2002) Serum 25-hydroxyvitamin D status of adolescents and adults in two seasonal subpopulations from NHANES III. Bone 30:771–777PubMedCrossRef

23.

Dawson-Hughes B, Mithal A, Bonjour JP, Boonen S, Burckhardt P, Fuleihan GE et al (2010) IOF position statement vitamin D recommendations for older adults. Osteoporos Int 21:1151–1154PubMedCrossRef

24.

Holick MF, Binkley NC, Bischoff-Ferrari HA, Gordon CM, Hanley DA, Heaney RP, Murad MH, Weaver CW (2011) Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 96:1911–1930PubMedCrossRef

25.

Gómez Alonso C, Naves ML, Fernández JL, Díaz-López JB, Fernández MT, Cannata J (2003) Vitamin D status and secondary hyperparathyroidism: the importance of 25-hydroxyvitamin D cut-off levels. Kidney Int 85:S44–S48CrossRef

26.

González-Molero I, Morcillo S, Valdés S, Pérez-Valero V, Botas P, Delgado E, Hernández D, Olveira G, Rojo G, Gutiérrez-Repiso C, Rubio-Martín E, Menéndez E, Soriguer F (2011) Vitamin D deficiency in Spain: a population-based cohort study. Eur J Clin Nutr 65:321–328PubMedCrossRef

27.

Quesada JM, Jans I, Benito P, Jimenez JA, Bouillon R (1989) Vitamin D status of elderly people in Spain. Age Ageing 18:392–397PubMedCrossRef

28.

Pérez-Llamas F, López-Contreras MJ, Blanco MJ, López-Azorín F, Zamora S, Moreiras O (2008) Seemingly paradoxical seasonal influences on vitamin D status in nursing-home elderly people from Mediterranean area. Nutrition 24:414–420PubMedCrossRef

29.

Calatayud M, Jódar E, Sánchez R, Guadalix S, Hawkins F (2009) Prevalence of deficient and insufficient vitamin D levels in a young healthy population. Endocrinol Nutr 56:164–169PubMedCrossRef

30.

Gómez-de-Tejada MJ, Navarro MD, Saavedra P, Quesada JM, Jódar E, Sosa M (2014) Prevalence of osteoporosis, vertebral fractures and hypovitaminosis D in postmenopausal women living in a rural environment. Maturitas 77:282–286CrossRef

31.

Quesada-Gómez JM, Diaz-Curiel M, Sosa-Henriquez M, Malouf-Sierra J, Nogues-Solan X, Gomez-Alonso C, Rodriguez-Mañas L, Neyro-Bilbao JL, Cortes X, Delgadillo J (2013) Low calcium intake and inadequate vitamin D status in postmenopausal osteoporotic women. J Steroid Biochem Mol Biol 136:175–177PubMedCrossRef

32.

Docio S, Riancho JA, Pérez A, Olmos JM, Amado JA, González-Macías J (1998) Seasonal deficiency of vitamin D in children: a potential target for osteoporosis-preventing strategies. J Bone Miner Res 13:544–548PubMedCrossRef

33.

Úbeda N, Basagoiti M, Alonso-Aperte E, Varela-Moreiras G (2007) Hábitos alimentarios, estado nutricional y estilos de vida en una población de mujeres menopáusicas españolas. Nutr Hosp 22:313–321PubMed

34.

Bernal M, Cortés G, Giner A, Orden I, Horno M, Benedicto I (2010) Ha mejorado la dotación de vitamina D3 en España? Actuales niveles en una muestra de población. Rev Esp Geriatr Gerontol 45:15–18CrossRef

35.

Mc Donald HM, Mavroeidi A, Barr RJ, Black AJ, Fraser WD, Reid DM (2008) Vitamin D status in postmenopausal women living at higher latitudes in the UK in relation to bone health, overweight, sunlight exposure and dietary vitamin D. Bone 42:996–1003CrossRef

36.

Webb AR, Kline L, Holick MF (1988) Influence of season and latitude on the cutaneous synthesis of vitamin D3: exposure to winter sunlight in Boston and Edmonton will not promote vitamin D3 synthesis in human skin. J Clin Endocrinol Metab 67:373–378PubMedCrossRef

37.

McLaughin J, Holick MF (1985) Aging decreases the capacity of human skin to produce vitamin D3. J Clin Invest 76:1536–1538CrossRef

38.

Wacker M, Holick MF (2013) Sunlight and vitamin D: a global perspective for health. Dermatoendocrinol 5:51–108PubMedPubMedCentralCrossRef

39.

Tovar-Sánchez A, Sánchez-Quiles D, Basterretxea G, Benedé JL, Chisvert A, Salvador A, Moreno-Garrido I, Blasco J (2013) Sunscreen products as emerging pollutants to coastal waters. PLoS One 8, e65451PubMedPubMedCentralCrossRef

40.

Patel S, Hyer S, Barron J (2007) Glomerular filtration rate is a major determinant of the relationship between 25-hydroxyvitamin D and parathyroid hormone. Calcif Tissue Int 80:221–226PubMedCrossRef

41.

Pasco JA, Henry MJ, Nicholson GC, Brennan SL, Kotowicz MA (2009) Behavioural and physical characteristics associated with vitamin D status in women. Bone 44:1085–1091PubMedCrossRef

42.

Nimitphong H, Sritara C, Chailurkit LO, Chanprasertyothin S, Ratanachaiwong W, Sritara P, Ongphiphadhanakul B (2015) Relationship of vitamin D status and bone mass according to vitamin D-binding protein genotypes. Nutr J 14:29PubMedPubMedCentralCrossRef

43.

Institute of Medicine (IOM) (2011) Dietary reference intakes for calcium and vitamin D. National Academies Press, Washington, DC

44.

Aloia JF, Talwar SA, Pollack S, Feuerman M, Yeh JK (2006) Optimal vitamin D status and serum parathyroid hormone concentrations in African American women. Am J Clin Nutr 84:602–609PubMedPubMedCentral

45.

Vieth R, Ladak Y, Walfish PG (2003) Age-related changes in the 25-hydroxyvitamin D versus parathyroid hormone relationship suggest a different reason why older adults require more vitamin D. J Clin Endocrinol Metab 88:185–191PubMedCrossRef

Title: Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults
Authors: J. M. Olmos
J. L. Hernández
P. García-Velasco
J. Martínez
J. Llorca
J. González-Macías
Publication date: 01-01-2016
Publisher: Springer London
Published in: Osteoporosis International / Issue 1/2016
Print ISSN: 0937-941X
Electronic ISSN: 1433-2965
DOI: https://doi.org/10.1007/s00198-015-3219-6

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Serum 25-hydroxyvitamin D, parathyroid hormone, calcium intake, and bone mineral density in Spanish adults

Abstract

Summary

Introduction

Methods

Results

Conclusions

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Introduction

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 1/2016

Bone remodeling markers: so easy to measure, so difficult to interpret

Diabetes mellitus and risk of hip fractures: a meta-analysis

Bone status in glucocorticoid-treated men and women

Strontium ranelate as an adjuvant for fracture healing: clinical, radiological, and ultrasound findings in a randomized controlled study on wrist fractures

Comorbidity indices for clinical trials: adaptation of two existing indices for use with the FREEDOM trial in women with postmenopausal osteoporosis

Sclerostin-antibody treatment of glucocorticoid-induced osteoporosis maintained bone mass and strength